James M Crawford, MD, PhD

Chair, Department of Pathology and Laboratory Medicine / Senior Vice President Laboratory Services, Zucker School of Medicine, Hofstra/Northwell / Northwell Health System

Dr. James Crawford is Chair of the Department of Pathology and Laboratory Medicine, Zucker School of Medicine at Hofstra/Northwell, and Senior Vice President of Laboratory Services for the Northwell Health System, a position he has held since 2009. Prior to that, for 9 years he was Chair of the Department of Pathology, Immunology and Laboratory Medicine at the University of Florida College of Medicine, Gainesville, FL. Dr. Crawford has served as Editor-in-Chief of Laboratory Investigation, President of the Association of Pathology Chairs (APC), Chair of the Council of Academic Societies of the Association of American Medical Colleges (AAMC) and member of the AAMC Board of Directors. He currently is Editor-in-Chief of the APC journal Academic Pathology. Dr. Crawford has been heavily involved in advocacy for healthcare, including chairing the Board of Directors for “PathPAC” of the College of American Pathologists. He is founding member of Project Santa Fe, which is providing leadership to drive the “Clinical Lab 2.0” movement, namely, establishing the evidence base for valuation of the clinical laboratory in the next era of American health care. This involves establishing the value statements for laboratory as a driver of both better patient outcomes and improved cost effectiveness of delivering health—and wellness—care.

James is speaking at

October 24, 2018
8:00 am - 3:30 pm
Columbia B

Speakers

  • Beth Bailey (Speaker) Director, Strategic Development, TriCore Reference Laboratories
  • Lisa Jean Clifford (Speaker) COO & Chief Strategy Officer, Gestalt Diagnostics
  • Linda Smith (Speaker) Vice President, Laboratory Services, SSM Health
  • Steve Stonecypher (Speaker) Partner, Shipwright Healthcare Group
  • Barb Senters (Speaker) Chief Compliance & Ethics Officer, Sonic Healthcare USA
  • James M Crawford, MD, PhD (Speaker) Chair, Department of Pathology and Laboratory Medicine / Senior Vice President Laboratory Services, Zucker School of Medicine, Hofstra/Northwell / Northwell Health System
  • Patricia Goede (Speaker) VP Clinical Informatics, XIFIN, Inc.
  • Julie Ramage (Speaker) National Account Director, Diagnostics, Pfizer Oncology
  • Shally Madan (Speaker) Co-founder & COO, LuminateHealth

Description

What does FutureLab look like? What does your lab need to focus on to be ready to operate in a Clinical Lab 2.0 environment?

In this one-day interactive Summit, strategic planning experts and lab leaders will guide attendees step-by-step through the process of connecting trends to trajectories and developing a competitive roadmap for your diagnostic lab using Clinical Lab 2.0 ideology.

In the morning sessions, we’ll conduct an external scan and learn about the market opportunities and threats facing laboratories, such as new customers, alternative markets and revenue streams, the compliance/legal environment, and non-traditional competition. We’ll also explore emerging FutureLab technology and innovation, such as artificial intelligence and innovation in pathology.

In the afternoon, we’ll do an internal scan. Attendees will learn how to assess their own labs’ strengths and weaknesses to defend against the threats and to maximize the opportunities. And finally, we’ll connect the dots and target specific strategies you need to become a successful FutureLab. You’ll walk away with a practical Clinical Lab 2.0 toolbox to facilitate future planning.

Session Objectives:

  • Engage subject matter experts to explore external market opportunities and threats in order to paint a canvas of FutureLab;
  • Target your FutureLab opportunities based on your lab’s strengths; begin to understand your lab’s possible gaps in FutureLab; and
  • Determine action steps and target additional learning at Lab Institute 2018.

October 25, 2018
10:45 am - 11:30 am
Regency B/C/D

Speaker

  • James M Crawford, MD, PhD (Speaker) Chair, Department of Pathology and Laboratory Medicine / Senior Vice President Laboratory Services, Zucker School of Medicine, Hofstra/Northwell / Northwell Health System

Description

“This is your call to be part of the Lab 2.0 Movement”
The concept of “Clinical Lab 2.0” was introduced in 2017 by Project Santa Fe, with the goal of establishing the evidence base for valuation of the clinical laboratory in the next era of American health care. In this session, lessons learned from ongoing demonstration projects will be shared, with the goal of equipping attendees to transform their own work effort from transactional 1.0 involvement in health care delivery, to a leadership position in driving 2.0 Health Care. This is also your call to be part of the 2.0 movement, and to help us collectively drive the future success of clinical laboratories. Learning objectives are:

  • To understand the substantial asset that the clinical laboratory constitutes for integrated health systems
  • To identify the tools and skill sets needed to transform from delivery of 1.0 to delivery of 2.0 laboratory services
  • To gain insight into the evidence base that will favorably influence the decision-making of health system leaders, payers, and consumers about what laboratory should be their provider

Add to my calendar

Add to Google Add to Outlook (.ics)

Create your personal schedule through the official app, Whova!

Get Started